Cargando…
Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution
BACKGROUND: Postoperative pancreatic fistula (POPF) is a critical complication of pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC). Recent papers reported that serum carbohydrate antigen (CA)19-9 levels predicted long-term prognosis. We investigated whether preoperative serum...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617438/ https://www.ncbi.nlm.nih.gov/pubmed/36307795 http://dx.doi.org/10.1186/s12893-022-01825-3 |
_version_ | 1784820839832616960 |
---|---|
author | Sugita, Hiroki Okabe, Hirohisa Ogawa, Daisuke Hirao, Hiroki Kuroda, Daisuke Taki, Katsunobu Tomiyasu, Shinjiro Hirota, Masahiko |
author_facet | Sugita, Hiroki Okabe, Hirohisa Ogawa, Daisuke Hirao, Hiroki Kuroda, Daisuke Taki, Katsunobu Tomiyasu, Shinjiro Hirota, Masahiko |
author_sort | Sugita, Hiroki |
collection | PubMed |
description | BACKGROUND: Postoperative pancreatic fistula (POPF) is a critical complication of pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC). Recent papers reported that serum carbohydrate antigen (CA)19-9 levels predicted long-term prognosis. We investigated whether preoperative serum CA19-9 levels were associated with POPF in PDAC patients. METHODS: This cohort study was conducted at a single institution retrospectively. Clinicopathologic features were determined using medical records. RESULTS: Among of 196 consecutive patients who underwent pancreatectomy against PDAC, 180 patients whose CA19-9 levels were above the measurement sensitivity, were registered in this study. The patients consisted of 122 patients who underwent pancreaticoduodenectomy and 58 patients who underwent distal pancreatectomy. Several clinicopathological factors, including CA 19-9 level, as well as surgical factors were determined retrospectively based on the medical records. Patients with high CA19-9 levels had a significantly higher incidence of POPF than those with low levels (43.9 vs. 13.0%, P < 0.0001). The receiver operating characteristic curves calculated that the cutoff CA19-9 value to predict POPF was 428 U/mL. CA19-9, BMI, curability, and histology were statistically significant risk factors for POPF by univariate analysis. Multivariate analysis showed that CA19-9 and BMI levels were statistically significant independent risk factors for POPF. CA19-9 levels were correlated with both histology and curability. Disease free survival and overall survival of patients with higher levels of CA19-9 were significantly shorter than that of patients with lower levels of preoperative serum CA19-9. CONCLUSIONS: In patients undergoing pancreatectomy for PDAC, higher preoperative CA19-9 levels are a significant predictor for POPF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-022-01825-3. |
format | Online Article Text |
id | pubmed-9617438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96174382022-10-30 Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution Sugita, Hiroki Okabe, Hirohisa Ogawa, Daisuke Hirao, Hiroki Kuroda, Daisuke Taki, Katsunobu Tomiyasu, Shinjiro Hirota, Masahiko BMC Surg Research BACKGROUND: Postoperative pancreatic fistula (POPF) is a critical complication of pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC). Recent papers reported that serum carbohydrate antigen (CA)19-9 levels predicted long-term prognosis. We investigated whether preoperative serum CA19-9 levels were associated with POPF in PDAC patients. METHODS: This cohort study was conducted at a single institution retrospectively. Clinicopathologic features were determined using medical records. RESULTS: Among of 196 consecutive patients who underwent pancreatectomy against PDAC, 180 patients whose CA19-9 levels were above the measurement sensitivity, were registered in this study. The patients consisted of 122 patients who underwent pancreaticoduodenectomy and 58 patients who underwent distal pancreatectomy. Several clinicopathological factors, including CA 19-9 level, as well as surgical factors were determined retrospectively based on the medical records. Patients with high CA19-9 levels had a significantly higher incidence of POPF than those with low levels (43.9 vs. 13.0%, P < 0.0001). The receiver operating characteristic curves calculated that the cutoff CA19-9 value to predict POPF was 428 U/mL. CA19-9, BMI, curability, and histology were statistically significant risk factors for POPF by univariate analysis. Multivariate analysis showed that CA19-9 and BMI levels were statistically significant independent risk factors for POPF. CA19-9 levels were correlated with both histology and curability. Disease free survival and overall survival of patients with higher levels of CA19-9 were significantly shorter than that of patients with lower levels of preoperative serum CA19-9. CONCLUSIONS: In patients undergoing pancreatectomy for PDAC, higher preoperative CA19-9 levels are a significant predictor for POPF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-022-01825-3. BioMed Central 2022-10-28 /pmc/articles/PMC9617438/ /pubmed/36307795 http://dx.doi.org/10.1186/s12893-022-01825-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Sugita, Hiroki Okabe, Hirohisa Ogawa, Daisuke Hirao, Hiroki Kuroda, Daisuke Taki, Katsunobu Tomiyasu, Shinjiro Hirota, Masahiko Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution |
title | Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution |
title_full | Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution |
title_fullStr | Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution |
title_full_unstemmed | Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution |
title_short | Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution |
title_sort | preoperative serum ca19-9 predicts postoperative pancreatic fistula in pdac patients: retrospective analysis at a single institution |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617438/ https://www.ncbi.nlm.nih.gov/pubmed/36307795 http://dx.doi.org/10.1186/s12893-022-01825-3 |
work_keys_str_mv | AT sugitahiroki preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution AT okabehirohisa preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution AT ogawadaisuke preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution AT hiraohiroki preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution AT kurodadaisuke preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution AT takikatsunobu preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution AT tomiyasushinjiro preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution AT hirotamasahiko preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution |